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Abstract
The formyl peptide receptor 1 (FPR1) is mainly expressed by mammalian phagocytic leukocytes and plays a role in
chemotaxis, killing of microorganisms through phagocytosis, and the generation of reactive oxygen species. A large number
of ligands have been identified triggering FPR1 including formylated and non-formylated peptides of microbial and
endogenous origin. While the expression of FPR1 in neutrophils has been investigated intensively, knowledge on the
regulation of FPR1 expression in polarized macrophages is lacking. In this study we show that primary human neutrophils,
monocytes and resting macrophages do express the receptor on their cell surface. Polarization of macrophages with IFNc,
LPS and with the TLR8 ligand 3M-002 further increases FPR1 mRNA levels but does not consistently increase protein
expression or chemotaxis towards the FPR1 ligand fMLF. In contrast, polarization of primary human macrophages with IL-4
and IL-13 leading to the alternative activated macrophages, reduces FPR1 cell surface expression and abolishes chemotaxis
towards fMLF. These results show that M2 macrophages will not react to triggering of FPR1, limiting the role for FPR1 to
chemotaxis and superoxide production of resting and pro-inflammatory M1 macrophages.
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Introduction
The formyl peptide receptor 1 (FPR1) belongs to a family of G
protein-coupled pattern recognition receptors, which are mainly
expressed by mammalian phagocytic leukocytes and are key
players in innate immunity and host defence [1,2,3]. In
neutrophils, signalling through the FPR1 receptor plays a role in
chemotaxis, killing of microorganisms through phagocytosis, and
generation of reactive oxygen species [2]. In addition, FPR1 is
thought to play a role in sensing of endogenous signals of
dysfunctional cells, which should attract leukocytes to the site of
inflammation and tissue damage [2].
The first ligands identified for FPR1 were the N-formylated
peptides from bacteria, however, later it was found that such N-
formylated peptides could also derive endogenously from mito-
chondria, released as a result of severe cell dysfunction or cell
death [1]. However, it is currently not clear whether these
mitochondria derived N-formylated peptides are produced in vivo
[2]. In addition, a large number of microbial and endogenous
peptides of various compositions have been identified as agonists
for FPR1. These include formylated and non-formylated peptides
of microbial and endogenous origin, like the GP-41 envelope
protein of the human immuno-deficiency virus (HIV), annexin-1,
and a list of peptides from peptide libraries [2,4].
Several intracellular signalling pathways regulating chemotaxis
and superoxide production are triggered by FPR1 in neutrophils
[2]. Chemotaxis towards pathogens is mediated by activated Gai
involving the PI3K family of kinases [5,6], while several signalling
pathways have been identified for superoxide production neces-
sary for the oxidative burst. Superoxide production was shown to
be transduced by PI3K mediated signalling pathways but also Rac
[7] and PKC dependent pathways [8] are involved in superoxide
production upon FPR1 triggering.
In addition, the receptor is regulated by desensitization upon
activation with ligands [9]. After stimulation of the FPR1 receptor,
the cellular responses rapidly decline in intensity and the cells
become refractory to subsequent stimulations with the same
agonist. This mechanism common to G protein-coupled receptors
results at least partially from phosphorylation of the agonist-
occupied receptor by G protein-coupled receptor kinases, leading
to its internalization [10,11].
FPR1 is highly expressed in myeloid cells like neutrophils,
monocytes and macrophages [12] and the promoter region of the
gene has been characterized identifying a myeloid specific
transcription factor necessary for transcription of the gene [13].
While the expression of FPR1 in neutrophils has been investigated
intensively, knowledge on regulation of FPR1 expression in
polarized macrophages is lacking. In this study we investigate
the regulation of FPR1 expression and function in primary human
macrophages. We show that most polarized M1 macrophages do
express FPR1 on their cell surface, while IL-4 and IL-13 polarized
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M2 macrophages do not have functional FPR1 cell surface
expression.
Materials and Methods
Material
The recombinant human cytokines IL-1b, IL-3, INFc, and
TNFa as well as lipopolysaccharide (LPS) and the Toll-Like
Receptor (TLR) 3 agonist Poly I:C, were purchased from Sigma-
Aldrich (Buchs, Switzerland). IL-4, IL-6, IL-13 were obtained
from R&D Systems Europe Ltd. (Abingdon, United Kingdom).
The TLR9 ligand, CpG-oligodeoxynucleotides (CpG), was syn-
thesized by Microsynth (Balgach, Switzerland). The TLR7 and
TLR8 ligands 3M-001 and 3M-002, respectively, were purchased
from 3M Pharmaceuticals (St. Paul, MN, USA). FPR1 antibody
(Formyl peptide receptor 1, anti-human, monoclonal antibody)
was purchased from R&D Systems Europe Ltd.
Preparation of Human Peripheral Monocytes and Cell
Culture
White blood cells from healthy blood donors were isolated from
commercially available and anonymized buffy coats (Blutspende-
zentrum Zurich, Schlieren, Switzerland) using Histopaque–1077
gradient (Sigma-Aldrich). Peripheral human monocytes were
purified by capturing with anti-CD14 antibodies coupled to
MACS microbeads (Miltenyi Biotech, Bergisch Gladbach, Ger-
many). Monocytes were seeded with a density of 0.7*106 cells/ml
and were cultured for differentiation into macrophages for 7 days
at 37uC and 5% CO2 in RPMI-1640 (Sigma-Aldrich) supple-
mented with 5% Fetal Calf Serum (Bioconcepts, Allschwil,
Switzerland), 5% Human AB Serum (Sigma-Aldrich) and 1%
Penicillin/Streptomycin (Invitrogen, Zug, Switzerland). For the
stimulation experiments with the set of cytokines, the cells were
washed once with PBS (Bioconcept) and incubated in RPMI-1640
(Sigma-Aldrich) supplemented with 5% Human AB Serum
(Sigma-Aldrich), 1% Penicillin/Streptomycin (Invitrogen) and
the indicated cytokines for different periods.
Quantitative Real-Time PCR (qPCR)
Total amount of RNA was extracted using RNeasy Mini Kit
(Qiagen AG, Hombrechtikon, Switzerland) and the reverse
transcription reaction was performed with 0.5 mg RNA in
a 20 ml reaction using random primers (Invitrogen) with the
Superscript III Reverse Transcriptase (Invitrogen) according to the
manufacturer’s instructions. The qPCR reaction was done on
a LightCycler 480 system (Roche Diagnostics, Rotkreuz, Switzer-
land) utilizing the hot-start SYBR green method with the following
parameters: preheating for 10 min at 95uC, followed by 45 cycles
of denaturation for 5 sec at 95uC, annealing for 10 sec at 60uC
and extension for 6 sec at 72uC. The quantitative PCR included
50 ng cDNA, 0.5 mM forward and 0.5 mM reverse primer and 56
SYBR green master mix (Roche Diagnostics). Primers were
designed using the OLIGO 6.0 software (Molecular Biology
Insights, Inc., Cascade, USA) (sequences are listed in Table S1).
FACS Analysis
FACS analysis was performed using a monoclonal PE-labeled
anti-human FPR1/FPR antibody (Ab) and an IgG2a isotype
Figure 1. FPR1 cell surface expression on human neutrophils, monocytes, and macrophages. FACS analysis was performed to investigate
cell surface expression of FPR1. A) Neutrophils. B) Monocytes. C) 9 day old macrophages. Autofluorescence of the cells is shown in light grey, the
isotype control in grey and cells labeled with FPR1 Ab in black. D) Quantitative representation of the FPR1 median fluorescence intensity (antibody
MFI minus isotype MFI) NG: neutrophils (n = 3). MO: monocytes (n = 5). MA: 9 day old macrophages (n = 9).
doi:10.1371/journal.pone.0050195.g001
Regulation of the Human FPR1 Gene
PLOS ONE | www.plosone.org 2 November 2012 | Volume 7 | Issue 11 | e50195
control (both R&D Systems, Minneapolis, MN, USA). As a positive
control for the stimulations of the cells, CD206 and CD80 Ab
were used (BD Biosciences, San Jose, CA, USA). Briefly, cells were
resuspended in PBS containing 2.5% FCS and incubated in the
dark for 30 min at 4uC before analysis on a FACS Calibur
Analyzer (BD Biosciences, San Jose, CA, USA).
Chemotaxis Assay
A total of 105 macrophages were placed on a 96-well membrane
(5.7-mm diameter, 5-mm pore size; ChemoTX from Neuro Probe,
Gaithersburg, MD) in RPMI-1640 containing 0.1% BSA (Sigma-
Aldrich). The cells were allowed to migrate toward the chemo-
tactic factors at the indicated concentrations for 60 min. Migrated
cells were fixed (2% paraformaldehyde, VWR International AG,
Dietikon, Switzerland) and stained with DAPI (Sigma-Aldrich),
and migration was quantified as the total pixel count of DAPI-
stained nuclei under the fluorescence microscope (one photo per
membrane and two replicate wells per experiment). Migration
indices were calculated over control values. The Formyl-
Methionyl-Leucyl-Phenylalanine peptide (fLMF) (Sigma Aldrich)
was used as a positive control.
Characterization of Macrophages
To confirm the polarization of the resting macrophages into the
M1 (INFc, LPS) and M2 (IL-4, IL-13) subtypes following
stimulation, the expression of different markers characteristic for
the two subpopulations were measured (see Figure S1 and [14]).
INFc and LPS stimulation increased the mRNA expression of the
pro-inflammatory cytokines TNFa and/or IL-1b and the cell
surface expression of CD80. IL-4 and IL-13 stimulation increased
Figure 2. Regulation of FPR1 mRNA expression in human macrophages. A) Relative mRNA expression of FPR1 after stimulation of human
macrophages with different stimuli for 24 hours. IL-3 (20 ng/ml), IL-4 (10 ng/ml), IL-13 (10 ng/ml), IL-1b (5 ng/ml), IL-6 (10 ng/ml), INFc (50 ng/ml),
TNFa (1 ng/ml), CpG (100 ng/ml), LPS (100 ng/ml), Poly I:C (1 ng/ml), 3M-001 (3 mM), 3M-002 (3 mM). B) Time-course experiment of FPR1 mRNA
expression in macrophages stimulated with IL-4 (10 ng/ml) (dotted) and IL-13 (10 ng/ml) (white) for 24, 48 and 72 hours. The values are normalized
for GAPDH mRNA expression and are presented relative to non-stimulated control macrophages (black). Bars display the mean and the standard
deviation (6SD) of three independent experiments. *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0050195.g002
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the mRNA expression of the anti-inflammatory cytokine IL-10,
reduced the mRNA of the pro-inflammatory IL-1b and TNFa,
and increased the surface marker CD206.
Statistical Analysis
Statistical analysis was performed with Microsoft Office Excel
2003 (Microsoft Corporation, Redmond, CA, USA). The level of
FPR1 mRNA, protein and chemotaxis were compared using a two-
sided t-test and a two-sided p value of ,0.05 was considered
significant.
Results
Primary neutrophils, monocytes and resting macrophages
express high levels of FPR1 on the cell surface (Figure 1). To
investigate the regulation of the FPR1 gene in leukocytes, primary
human macrophages were stimulated with different pro- and anti-
inflammatory cytokines or TLR agonists for 24 hours and the
relative mRNA expression was measured by qPCR. Compared to
the mRNA expression of resting macrophages, stimulation with
IL-4 and IL-13 reduced FPR1 mRNA expression, while stimula-
tion with IFNc, LPS and with the TLR8 ligand 3M-002 further
increased the FPR1 mRNA in macrophages (Figure 2A). No
regulation of FPR1 mRNA levels was seen with IL-3, IL-1b, IL-6,
TNFa, the TLR9 ligand CpG, the TLR3 ligand Poly I:C, and the
TLR7 ligand 3M-001.
To corroborate the downregulation of the FPR1 mRNA
following IL-4 and IL-13 stimulation, we measured the mRNA
levels in a time course experiment for 72 hours (Figure 2B). Both
cytokines reduced the FPR1 mRNA already after stimulation for
24 hours to less than 50% and after 48 hours to less than 20% of
the level of resting macrophages (Figure 2B).
To investigate whether the regulation on the mRNA level
translated into differential cell surface expression of FPR1, we
analyzed the individually stimulated human macrophages for
FPR1 cell surface expression by FACS analysis (Figure 3A).
Similar to the results obtained on the mRNA level, we observed
Figure 3. Regulation of FPR1 cell surface expression in human macrophages. FACS analysis was performed to investigate cell surface
expression of FPR1 upon treatment with the indicated stimuli. A) FPR1 protein expression after stimulation of human macrophages for 48 hours with
stimuli which were shown to regulate FPR1 mRNA expression (IL-4 (10 ng/ml), IL-13 (10 ng/ml), INFc (50 ng/ml), LPS (100 ng/ml), 3M-002 (3 mM)). B)
Time-course experiment of FPR1 protein expression in controls macrophages (black), or macrophages stimulated with IL-4 (10 ng/ml) (dotted) and IL-
13 (10 ng/ml) (white) for 24, 48 and 72 hours. Values are presented relative to unstimulated macrophages. Bars display the mean and the standard
deviation (6SD) of three independent experiments. *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0050195.g003
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a decrease in FPR1 cell surface expression following stimulation of
macrophages with IL-4 and IL-13 and an increase following IFNc
stimulation. However, no increase in FPR1 cell surface expression
was observed following LPS and TLR8 (3M-002) stimulation,
although both of these stimulations led to increased FPR1 mRNA
levels. In addition we observed no increase in intracellular FPR1
staining following stimulation of macrophages with these stimuli
(data not shown). In contrast, in a time-course experiment, IL-4
and IL-13 both led to sustained reduction in cell surface expression
of FPR1 for up to 72 hours following stimulation (Figure 3B).
To show that the reduced cell surface expression of FPR1 in IL-
4 and IL-13 stimulated human macrophages has functional
relevance, we investigated chemotaxis of macrophages towards
the FPR1 ligand fLMF (Figure 4). As expected from the cell
surface expression of FPR1, resting macrophages migrated
towards the chemotactic stimulus. In contrast, macrophages
stimulated by IL-4 and IL-13, which have reduced mRNA and
protein expression of FPR1, showed no chemotaxis towards fLMF.
This indicates that IL-4 and IL-13 stimulated M2 macrophages
will not respond to FPR1 ligands unlike resting macrophages or
pro-inflammatory M1 macrophages stimulated with IFNc or LPS.
Discussion
We studied the regulation of FPR1 receptor expression in
primary human macrophages and observed that neutrophils,
monocytes and resting macrophages express the receptor on their
cell surface. Polarization of macrophages towards a pro-in-
flammatory M1 macrophage further increased FPR1 mRNA
levels but did not consistently increase protein expression or
chemotaxis towards the FPR1 ligand fMLF. In contrast, polari-
zation of primary human macrophages with IL-4 and IL-13
leading to the alternatively activated M2 macrophages, reduces
FPR1 cell surface expression and abolishes chemotaxis towards
fMLF. These results show that M2 macrophages will not react to
triggering of FPR1, limiting the role for FPR1 to chemotaxis and
superoxide production in resting and pro-inflammatory M1
macrophages.
Stimulation of FPR1 by TLR4 agonists has previously been
observed in mouse macrophages and the mechanism involved in
this increase has been investigated [15,16]. These data demon-
strated that FPR1 mRNA levels are dramatically elevated in both
macrophages and neutrophils following exposure to LPS and that
this resulted both from elevated transcription and from stabiliza-
tion of the FPR1 mRNA [16]. In this line, higher binding of the
fLMF peptide has been observed in leukocytes from patients
suffering from Crohn’s disease or emphysema indicating that
FPR1 expression on leukocytes may serve as a marker for systemic
inflammation [17,18]. Our data in human primary macrophages
corroborate these findings and extend the number of stimuli
leading to FPR1 upregulation by additionally identifying IFNc
and triggering of TLR8 as effective stimuli. IFNc has been shown
to induce effects resulting in heightened immune surveillance and
immune system function during infection and to promote M1
macrophage polarization and activation [19]. In contrast, TLR8
signalling is thought to be rather specific for triggering immune
responses via recognition of viral RNA in infected cells. TLR8 is
one of pattern recognition receptors which is triggered by viral
single stranded RNA and which was shown to stimulate
macrophages to secrete IFNa and pro-inflammatory, as well as
regulatory cytokines [20]. Since both of these stimuli increase
FPR1 expression it is tempting to speculate that FPR1 may have
a role in host responses to viral infections in addition to its
proposed role in fighting bacterial infection. In this line the GP-41
envelope protein of the human immuno-deficiency virus (HIV)
[21] and a secreted peptide from Herpes simplex virus-2 (HSV)
[22] were shown to specifically activate the FPR1 receptor, and
hence to modulate innate immunity during viral infection.
However, whether FPR1 has a role in immune surveillance or
whether HIV-1 and HSV-2 have evolved to desensitize the
effector functions of FPR1, is not known [23].
While the pro-inflammatory stimulation of macrophages raises
or at least conserves FPR1 cell surface expression, stimulation of
macrophages with IL-4 and IL-13 abolishes FPR1 receptor
expression and functionality in polarized M2 macrophages.
Similar results were obtained on the mRNA level when mouse
peritoneal macrophages were stimulated with IL-4 or IL-13 [24].
Figure 4. fLMF chemotaxis assays with human macrophages. Control (Ctrl) and IL-4 (10 ng/ml), IL-13 (10 ng/ml), IFNc (50 ng/ml), LPS
(100 ng/ml), and 3M-002 (3 mM) stimulated macrophages were allowed to migrate towards the chemotactic factor fLMF (+). Medium without
chemotactic factor (2) was used as control for basal migration in each experiment. Graphs show the mean migration index compared to each
individual control (n = 3) and error bars display the standard deviation (6SD). *p,0.05; **p,0.01.
doi:10.1371/journal.pone.0050195.g004
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In these mouse macrophages, IL-4 and IL-13 suppressed the
expression of FPR1 mRNA by a Stat6 dependent mechanism,
which eliminated primary transcripts prior to maturation and
depended on the constitutive instability of pre-existing FPR1
mRNA [24]. Our results expand these findings showing that also
cell surface expression of the receptor and chemotaxis towards
fMLF are abolished in M2 macrophages. Such a downregulation
by the Th(2) cytokines is in line with the presumed role of FPR1 as
a pro-inflammatory receptor supporting chemotaxis and superox-
ide production in leukocytes. While microbial peptides act as
chemoattractants to recruit neutrophils to the site of challenge,
where they phagocytose invading microorganisms to protect the
host, the acute inflammation has a programmed fate to resolve
inflammation upon clearance of the microorganisms to protect the
host against unnecessary tissue damage [25]. Resolution of
inflammation is part of this program to promote the homeostatic
restoration of normal tissue structure and function, and IL-4 is
a prototypic mediator of such activity which is known to promote
the development of a Th(2) response [26,27]. Downregulation of
FPR1 in M2 macrophages indicates that FPR1 may not be
necessary for the non-phlogistic alternative macrophage, clearing
the inflamed tissue from apoptotic cells and microorganisms
[28,29].
In summary, we show that primary human neutrophils,
monocytes and most polarized macrophages do express FPR1
on their cell surface, while IL-4 and IL-13 polarized M2
macrophages do not express functional FPR1 on their cell surface.
These data argue for a role of FPR1 in resting and classically
activated macrophages to support chemotaxis and superoxide
production, while non-phlogistic alternative macrophages cannot
use it.
Supporting Information
Figure S1 Measurement of the different M1 markers
after stimulation of human macrophages with IFNc
(50 ng/ml)) for 48 hrs (surface marker CD80) or 24 hrs
(relative expression of IL-1b and TNFa). A: relative mRNA
expression of IL-1b and TNFa normalized for GAPDH as fold
induction of non-stimulated cells. B: FACS analysis of CD80
expression on non-stimulated cells (left panel) and on stimulated
cells (right panel). Autofluorescence of the cells is shown in light
grey, the isotype control in grey and cells labeled with CD80
antibody in black. MFl: median fluorescence intensity.
(TIF)
Table S1 Oligonucleotides used for quantitative RT-PCR.
(DOC)
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